89 results
Page 2 of 5
424B5
9zqs7y
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
yubupqnb79bqo8znye6
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K/A
EX-99.1
ezp 2e9zvvk85gauh
23 Nov 20
Consolidated Financial Statements
12:00am
8-K/A
EX-99.2
c421 y6h5a89lszmji
23 Nov 20
Consolidated Financial Statements
12:00am
8-K/A
EX-99.3
0jgblfk9v4tu
23 Nov 20
Consolidated Financial Statements
12:00am
8-K
EX-10.3
rbk6 piakho84fw
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
ic36y
28 Aug 20
Prospectus supplement
4:31pm
425
xdtbf32z
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-2.1
s9a aamfkn1e02
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
DEFA14A
v04v 6c0jbzf7e
29 Apr 20
Additional proxy soliciting materials
4:05pm
S-3ASR
x1f237o1gwg33ebqulzk
20 Apr 20
Automatic shelf registration
4:59pm